Viewing Study NCT04790851


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2025-12-25 @ 9:36 PM
Study NCT ID: NCT04790851
Status: COMPLETED
Last Update Posted: 2021-10-20
First Post: 2021-03-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4
Sponsor: China National Biotec Group Company Limited
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: COVAX+PPV23+IIV4-Beijing
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None OTHER_GOV View
None OTHER View
None OTHER_GOV View